Kbc Group Nv Amgen Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Amgen Inc stock. As of the latest transaction made, Kbc Group Nv holds 142,825 shares of AMGN stock, worth $45.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

142,825

Previous 144,285 1.01%

Holding current value

$45.1 Million

Previous $41 Million 8.78%

% of portfolio

0.13%

Previous 0.13%

43 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $383,615 - $466,192	-1,460 Reduced 1.01%	142,825 $44.6 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $41.9 Million - $50.6 Million	-155,888 Reduced 51.93%	144,285 $41 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $6.8 Million - $7.67 Million	-26,603 Reduced 8.14%	300,173 $86.5 Million
Q3 2023 Feb 15, 2024	BUY	$218.65 - $271.46 $16.2 Million - $20.1 Million	73,999 Added 22.59%	401,578 $108 Million
Q2 2023 Feb 15, 2024	BUY	$214.27 - $253.37 $7.78 Million - $9.2 Million	36,308 Added 12.47%	327,579 $72.7 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $9.4 Million - $11.1 Million	-43,861 Reduced 11.83%	326,776 $72.6 Million
Q1 2023 Feb 14, 2024	BUY	$225.79 - $275.2 $12.9 Million - $15.7 Million	57,019 Added 18.13%	371,440 $89.8 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $18.1 Million - $22.1 Million	80,156 Added 27.59%	370,637 $89.6 Million
Q4 2022 Feb 14, 2024	BUY	$229.03 - $291.01 $7.59 Million - $9.65 Million	33,156 Added 11.79%	314,421 $82.6 Million
Q3 2022 Feb 15, 2024	SELL	$224.46 - $253.15 $2 Million - $2.25 Million	-8,902 Reduced 2.97%	291,271 $65.7 Million
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $2.66 Million - $3 Million	11,853 Added 4.25%	290,481 $65.5 Million
Q2 2022 Feb 14, 2024	BUY	$230.71 - $256.74 $30.9 Million - $34.4 Million	134,140 Added 91.17%	281,265 $68.4 Million
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $30.3 Million - $33.8 Million	131,503 Added 89.38%	278,628 $67.8 Million
Q1 2022 Feb 14, 2024	SELL	$219.27 - $242.57 $9.07 Million - $10 Million	-41,362 Reduced 21.94%	147,125 $35.6 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $9.07 Million - $10 Million	-41,362 Reduced 21.94%	147,125 $35.6 Million
Q4 2021 Feb 14, 2024	SELL	$198.88 - $227.6 $22.2 Million - $25.4 Million	-111,686 Reduced 37.21%	188,487 $42.4 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $1.98 Million - $2.26 Million	-9,939 Reduced 5.01%	188,487 $42.4 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $2.38 Million - $2.79 Million	-11,215 Reduced 5.35%	198,426 $42.2 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $8.14 Million - $9.04 Million	34,866 Added 19.95%	209,641 $51.1 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $11.1 Million - $13 Million	-50,201 Reduced 22.31%	174,775 $43.5 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $13.2 Million - $15.7 Million	-60,981 Reduced 21.33%	224,976 $51.7 Million
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $202,972 - $225,721	865 Added 0.3%	285,957 $72.7 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $8.46 Million - $10.4 Million	42,787 Added 17.66%	285,092 $67.2 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $12.8 Million - $17 Million	70,244 Added 40.83%	242,305 $49.1 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $2.52 Million - $3.24 Million	-13,321 Reduced 7.19%	172,061 $41.5 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $32.2 Million - $38.6 Million	184,808 Added 32196.52%	185,382 $35.9 Million
Q2 2019 Dec 03, 2019	SELL	$166.7 - $195.41 $37.3 Million - $43.7 Million	-223,568 Reduced 99.74%	574 $106,000
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $37.3 Million - $43.7 Million	223,568 Added 38949.13%	224,142 $0
Q1 2019 Dec 03, 2019	SELL	$180.87 - $203.88 $40.4 Million - $45.6 Million	-223,513 Reduced 99.74%	574 $109,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $40.3 Million - $45.4 Million	222,804 Added 17365.86%	224,087 $0
Q4 2018 Dec 03, 2019	SELL	$178.4 - $208.25 $16.1 Million - $18.8 Million	-90,069 Reduced 98.6%	1,283 $250,000
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $16 Million - $18.7 Million	89,949 Added 6411.19%	91,352 $17.8 Million
Q3 2018 Dec 03, 2019	SELL	$185.29 - $208.89 $17.1 Million - $19.3 Million	-92,492 Reduced 98.51%	1,403 $291,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $17.1 Million - $19.3 Million	92,492 Added 6592.44%	93,895 $0
Q2 2018 Dec 03, 2019	SELL	$166.05 - $186.51 $15 Million - $16.9 Million	-90,528 Reduced 98.47%	1,403 $259,000
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $15 Million - $16.9 Million	90,423 Added 5996.22%	91,931 $0
Q1 2018 Dec 03, 2019	SELL	$169.43 - $198.0 $16 Million - $18.7 Million	-94,408 Reduced 98.43%	1,508 $257,000
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $16 Million - $18.7 Million	94,528 Added 6810.37%	95,916 $0
Q4 2017 Dec 03, 2019	SELL	$168.79 - $188.59 $17.4 Million - $19.4 Million	-102,935 Reduced 98.67%	1,388 $241,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $17.4 Million - $19.4 Million	103,040 Added 8031.18%	104,323 $0
Q3 2017 Dec 03, 2019	SELL	$167.29 - $191.0 $21.7 Million - $24.8 Million	-129,602 Reduced 99.02%	1,283 $239,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $21.7 Million - $24.8 Million	129,602 Added 10101.48%	130,885 $0
Q2 2017 Dec 03, 2019	BUY	N/A	1,283	1,283 $221,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account